Log In
Print this Print this

Topotecin, irinotecan hydrochloride hydrate

  Manage Alerts
Collapse Summary General Information
Company Daiichi Sankyo Co. Ltd.
DescriptionProdrug activated after oral administration that inhibits type 1 DNA Topoisomerase
Molecular Target
Mechanism of Action 
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentMarketed
Standard Indication Cancer (unspecified)
Indication DetailsCancer
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today